The best news of AMA Morning Rounds®: Week of January. 31, 2022, COVID-19 vaccine drops to record among 5- to 11-year-olds, CDC data shows, Bloomberg (2/3, Levin) reports "Covid-19 vaccine is lowest among 5-11-year-olds, the first injection to be approved. Levels later, "according to the Centers for Disease Control and Prevention. The data show that "the first seven-day dose dropped to an average of about 37,062 on January 3. This was the slowest week-long period since the government approved vaccines for these children on November 3, 2, and 5" compared to 75% of the total population. Only 31% of 11-year-olds have a chance. "
 |
| The best news of AMA Morning Rounds®: Week of January. 31, 2022, |
UNHCR: Without emergency intervention, the US will experience more than 1.2 million serious opioid-related overdoses in the next decade
MedPage Today (2/2, Grant) reports, "Experts warn that without urgent intervention, the United States will experience more than 1.2 million fatal opioid-related overdoses in the next decade" and thus "call for immediate action to stop the epidemic. In North America.". The Stanford Lancet Commission on the North American Opioid Crisis has developed an "opioid crisis model" that estimates that "there will be 1,220,000 fatal opioid overdoses in the United States from 2020 to 2029, underlining the value of the current crisis and recommendations for the future." The committee identified "unique areas" of the epidemic and made appropriate recommendations for each. "Executive summaries, supporting documents, and a related editorial were published online. 2 The Lancet.
The CDC study found that unvaccinated adults were 23 times more likely to be hospitalized with COVID-19 during the Omicron Wave than vaccinated and boosted adults.
The Hill (2/1, Sullivan) reports that "unvaccinated adults were 23 times more likely to be vaccinated during Omicron wave and hospitalized in COVID-19 than booster adults, according to a survey by the Center for Disease Control and Prevention." The highest number of cases and hospitalization rates are among those who have not yet been vaccinated, followed by those who have been vaccinated but not boosted, those who have been vaccinated and booster subjects have the highest protection. "The survey also found that" 5.3 times more than but it has not been strengthened.
MedPage Today (2/1, Walker) reports, "Overall, unvaccinated adults were more likely to be hospitalized ..., admitted to an intensive care unit ... and require mechanical ventilation."
Helio (2/1, Downey) reported for the study, the researchers assessed new coronavirus cases, hospitalizations, and mortality rates as of Nov. 11. 7, 2021, from January 3. 8, 2022 "in Los Angeles County.
The US Food and Drug Administration (FDA) gives full approval to Moderna. COVID-19 vaccine
The Wall Street Journal (1/31, Loftus, Sylvers, Fidler, Subscription Publications) reported that on Monday, the Food and Drug Administration fully approved the Moderna Spikevax COVID-19 vaccine for use in adults 18 years of age or older. The move marks the second vaccine to receive full approval after Pfizer-Biotech injections.
The Associated Press (1/31, Peroni) reports that the approval "has been strengthened by factual evidence from more than 200 million doses administered in the United States. Since the FDA cleared the shot in December 2020."
Reuters (1/31, Ironman, Khandikar) reported that "an estimated 75 million people have already received two doses of the modern vaccine in the United States, according to data from the US Centers for Disease Control and Prevention."
Omicron's 'hidden' variant seems to have an enhanced advantage and could pull the current spike
The New York Times (1/30, Zimmer) reports, "In recent days, headlines about the 'hidden' variant Omicron have led to the idea that a deadly new form of the coronavirus is secretly creating a catastrophic new wave of COVID-19.". Scientists say that this scenario is "highly unlikely." However, "a new form, whose scientific name is BA.2, and which is one of the three branches of the omicron viral family, can stop omicron mutations for the most part. Of world. "
Reuters (1/28, Smoot) reported, "The BA.2 subtype of the Omicron coronavirus variant now appears to have a significant growth advantage over the dominant type BA.1, the UK. The Health Safety Agency said on Friday." "The growth rate of BA.2 has increased compared to BA.1 in all regions of England where there are substantial cases to compare," the agency said, and "the apparent growth advantage is currently significant".
Bulletin has created AMA Morning Rounds news coverage jointly with Healthcare LLC. Subscribe to the morning round every day.
Up 3
